Charles A. Reinhart III, Chief Financial Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 708 shares at $33.02 ($23K) on 2018-06-04, disclosed to the SEC on 2018-06-06.
Open-market sale of $23k PCRX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PCRX | SELL | 2021-06-08 | $323K | — | Filing → |
| PCRX | SELL | 2020-06-08 | $138K | — | Filing → |
| PCRX | SELL | 2019-06-06 | $47K | — | Filing → |